Comparative dopaminergic and muscarinic antagonist activity of clozapine and haloperidol

Life Sciences

Volumn 58, Issue 7, 1996, Pages 585-590

  Sethy, Vimala H ^a   Ellerbrock, Brenda R ^a   Wu, Haiyan ^a  

^a PFIZER INC   (United States)

Author keywords

Antidopaminergic; Antimuscarinic; Cerebellar cGMP; Clozapine; Haloperidol; Oxotremorine; Quinpirole; Striatal ACh

Indexed keywords

ACETYLCHOLINE; CLOZAPINE; CYCLIC GMP; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; MUSCARINIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; OXOTREMORINE; QUINPIROLE;

ACETYLCHOLINE BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ANTAGONISM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; RAT; TISSUE LEVEL;

EID: 0030060782     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(95)02327-5     Document Type: Article

References (20)

1. H.-Y. MELTZER, B. BASTANI, K.Y. KOWN, L.F. RAMIREZ, S. BURNETT and J.A. SHARPE. Psychopharmacology 99 S68-S72 (1989).
2. J.A. LIEBERMAN, B.L. SALTZ, C.A. JOHNS, S. POLLACK, M. BORENSTEIN and J. KANE. Br. J. Psychiatry 158 503-510 (1991).
3. N. GUO, M.A. KLITENICK, C.S. THAM and H.C. FIBIGER. Neuroscience 65 747-756 (1995).
4. C. EVA, M. HADJICONSTANTINOU, N.H. NEFF and J.L. MEEK. Anal. Biochem. 143 320-324 (1984).
5. V.H. SETHY and J.W. FRANCIS. J. Pharm. Exp. Ther. 246 243-248 (1988).
6. W.P. BURKARD, E.P. BONETTI and W. HAEFELY. Eur. J. Pharmacol. 109 241-247 (1985).
7. V.H. SETHY and M.H. VAN WOERT. Nature 251 529-530 (1974).
8. V.H. SETHY and M.H. VAN WOERT. Res. Commun. Chem. Pathol. Pharmacol. 8 13-28 (1974).
9. G. RACAGNI, D.L. CHENEY, M. TRABUCCHI and E. COSTA. J. Pharmacol. Exp. Ther. 196 323-332 (1976).
10. J.A. FERRENDELLI, A.L. STEINER, D.B. McDOUGAL, Jr. and D.M. KIPNIS. Biochem. Biophys. Res. Comm. 41 1061-1067 (1970).
11. S. CONSOLO, H. LANDINSKY and S. GARATTINI. J. Pharm. Pharmacol. 26 275-276 (1974).
12. S.W. GUMULKA, V. DINNENDAHL, H.D. PETERS and P.S. SCHONHOFER. Naunyn-Schmiedeberg's Arch. Pharmacol. 293 75-80 (1976).
13. M.G. CORDA, G. BIGGIO and G.L. GOSSA. Brain Res. 188 287-290 (1980).
14. B. SCATTON. J. Pharmacol. Exp. Ther. 220 197-202 (1982).
15. S.K. HEMRICK-LUECKE, F.P. BYMASTER and R.W. FULLER. Soc. Neurosci. Abst. 20 1356 (1994).
16. E. RICHELSON and A. NELSON. Eur. J. Pharmacol. 103 197-204 (1984).
17. S.J. PEROUTKA and S.H. SNYDER. Am. J. Psychiat. 137 1518-1522 (1980).
18. S.H. SNYDER, D. GREENBERG and H.I. YAMAMURA. Arch. Gen. Psychiat. 31 58-61 (1974).
19. L. FARDE, A.L. NORDSTROM, F.A. WIESEL, S. PAULI, C. HALLDIN and G. SEDVALL. Arch. Gen. Psychiat. 49 538-544 (1992).
20. R. TANDON and J.F. GREDEN. Amer. J. Psychiatry 46 745-753 (1989).